Connection

Hiroaki Mitsuya to Cell Line, Tumor

Back to Details
This is a "connection" page, showing publications Hiroaki Mitsuya has written about Cell Line, Tumor.
Hiroaki Mitsuya
Connection Strength
0.168
Cell Line, Tumor
  1. GRL-079, a Novel HIV-1 Protease Inhibitor, Is Extremely Potent against Multidrug-Resistant HIV-1 Variants and Has a High Genetic Barrier against the Emergence of Resistant Variants. Antimicrob Agents Chemother. 2018 05; 62(5).
    View in: PubMed
    Score: 0.095
  2. Novel p97/VCP inhibitor induces endoplasmic reticulum stress and apoptosis in both bortezomib-sensitive and -resistant multiple myeloma cells. Cancer Sci. 2019 Oct; 110(10):3275-3287.
    View in: PubMed
    Score: 0.026
  3. MUC1/KL-6 expression confers an aggressive phenotype upon myeloma cells. Biochem Biophys Res Commun. 2018 12 09; 507(1-4):246-252.
    View in: PubMed
    Score: 0.025
  4. A xenograft model reveals that PU.1 functions as a tumor suppressor for multiple myeloma in vivo. Biochem Biophys Res Commun. 2017 05 13; 486(4):916-922.
    View in: PubMed
    Score: 0.022
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.